As of 2025-06-15, the Intrinsic Value of Dice Therapeutics Inc (DICE) is -9.51 USD. This DICE valuation is based on the model Peter Lynch Fair Value. With the current market price of 47.55 USD, the upside of Dice Therapeutics Inc is -120.01%.
Based on its market price of 47.55 USD and our intrinsic valuation, Dice Therapeutics Inc (DICE) is overvalued by 120.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.51 - -9.51 | -9.51 | -120.01% |
| P/E | (35.93) - (34.82) | (35.68) | -175.0% |
| DDM - Stable | (22.68) - (99.94) | (61.31) | -228.9% |
| DDM - Multi | (19.57) - (67.51) | (30.40) | -163.9% |
| Market Cap (mil) | 2,272.42 |
| Beta | 0.56 |
| Outstanding shares (mil) | 47.79 |
| Enterprise Value (mil) | 2,170.83 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.78% |
| Cost of Debt | 5.00% |
| WACC | 5.72% |